The 20 Best Acute Myeloid Leukemia (AML) Doctors Near Me in Lake Success, NY

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Erin Jou, MD is an attending physician at the Monter Cancer Center. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Jou is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Jou s practice is solely dedicated to the treatment of patients with benign and malignant hematologic disorders where she focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. She is involved in clinical research at Monter Cancer Center and actively enrolls patients in clinical trials. After graduating from the Pennsylvania State University, Dr. Jou earned her medical degree from Jefferson Medical College. She trained in Internal Medical and Hematology/Oncology at Montefiore Medical Center. Dr. Jou is an active member of the American Society of Hematology. Dr. Jou is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Jou is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Ruthee-lu Bayer is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Bayer is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bayer is board certified in American Board Of Internal Medicine.

Douglas Gladstone is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Gladstone is rated as an Advanced provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Hodgkin Lymphoma, and Bone Marrow Aspiration.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Advanced provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Melanoma, and Tissue Biopsy. Dr. Devoe is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Bradley Goldberg, MD, is an attending physician based at the Monter Cancer Center where he specializes in treating patients with both benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Goldberg maintains an active practice where he focuses on compassionate, personalized, and evidence-based multi-disciplinary care. He is part of the team rotating through the inpatient malignant hematology service at North Shore University Hospital (located on 7 Monti). Dr. Goldberg earned his medical degree at SUNY Downstate College of Medicine. He completed his internal medicine residency and his medical oncology and hematology fellowship at the Northwell Health program located at North Shore University Hospital and Long Island Jewish Medical Center. He is currently an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Goldberg is rated as an Advanced provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration. Dr. Goldberg is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as an Advanced provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Allen is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

David Chitty, DO, MSc is an Attending physician at the Monter Cancer Center where he specializes in malignant hematology with a particular clinical interest in acute leukemias. Board certified in Internal Medicine and Medical Oncology, Dr. Chitty maintains an active practice where he focuses on compassionate, personalized, evidence-based multi-disciplinary care. Dr. Chitty is a graduate of the Northwell Health Medical Oncology Translational Research Fellowship program. Prior to his Hematology/Oncology Fellowship, Dr. Chitty completed a residency in Internal Medicine at Maimonides Medical Center in Brooklyn, NY. A graduate of Nova Southeastern University School of Osteopathic Medicine, Dr. Chitty also earned a Master s in Science degree at the University of Ottawa, Ottawa, Canada in Cellular and Molecular Medicine. His work and research in the fields of medicine and oncology have been published in various peer-reviewed journals.Currently, his primary research interest is in the development and implementation of novel measurable residual disease assays. This work will allow clinicians to better implement targeted therapies into clinical practice for patients with resistant or residual disease following initial treatment. In addition, Dr. Chitty was instrumental in COVID-19 related research and continues to help push forward our understanding of COVID-19 disease in patients with cancer. Dr. Chitty is rated as an Advanced provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration. Dr. Chitty is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Medical Oncology.

Jaime Andres Suarez Londono, MD, MBA, MS, is the associate director of the adult transplantation and cellular therapy program at Northwell Cancer Institute. After completing medical school in Medellin, Colombia, Dr. Londono did a residency at Columbia University's St Luke's Roosevelt Hospital and a fellowship at Albert Einstein College of Medicine. He then spent eight years as an assistant professor at NYU Langone's Perlmutter Cancer Center, where he held several leadership roles in the NYU Grossman Long Island School of Medicine, and in the stem cell transplant programI was inspired to study hematology, oncology and transplantation because advances in the field are bringing new hope and transforming the lives of our patients in a positive way, says Dr. Londono, who believes that the future of cancer treatment lies in personalized medicine approaches, such as immunotherapy and genetic therapy.Dr. Londono joined Northwell Cancer Institute to continue his research on improving outcomes and expanding access to life saving stem cell transplants and cellular therapies. My goal is to advance the field so we can overcome the challenges of limited donor compatibility and patient eligibility, ensuring more people benefit from transformative treatments, he says.Dr. Londono and his team have authored more than a dozen scientific papers, and his current work is gaining international recognition. Beyond research, he is passionate about public outreach through the American Society of Hematology, serving as co- director of the of Health Volunteers Overseas LATAM. He was honored with the Golden Apple Award from the American Society of Hematology's Health Volunteers Overseas program in recognition of his contributions to global health.Dr. Londono is the founder of a startup dedicated to alleviating physician shortages in the United States. With an eye toward the future, Dr. Londono recently earned an MBA and an MS in Healthcare Leadership from Cornell University. I wanted to study the global healthcare landscape how medicine is delivered in different countries, what lessons we can learn, and the nuances of biotech companies and market dynamics, he explains.Outside of medicine, Dr. Londono pursues his passion for cuisine by taking classes at the American Culinary Institute. Yet his most rewarding moments come at the bedside. My patients are truly 'patient' often spending three or four weeks in the hospital. It's incredibly inspiring to witness their resilience, commitment, and humility. They are the reason I work so hard. Dr. Londono is rated as an Advanced provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Londono is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Jessica Caro is a Hematologist Oncology specialist and a Hematologist practicing medicine in Lake Success, New York. She has been practicing medicine for over 10 years. Dr. Caro is rated as an Advanced provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Febrile Neutropenia, Acute Myeloid Leukemia (AML), and Hemophagocytic Lymphohistiocytosis. Dr. Caro is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Ioannis Mantzaris is an Oncologist practicing medicine in Bronx, New York. Dr. Mantzaris is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Adult T-Cell Leukemia, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

I am a board certified hematologist and medical oncologist. I specialize in caring for patients with hematologic malignancies and specifically myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and aplastic anemia (AA). Dr. Shastri is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Adult T-Cell Leukemia, Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Dennis L. Cooper, MD, is Chief, Bone Marrow Transplantation and Professor, Medicine at Montefiore Einstein. His clinical focus centers on treating patients with multiple myeloma, hodgkin's lymphoma, non-hodgkin's lymphoma including bone marrow transplantation and CAR T cell therapy. Dr. Cooper is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Dr. William Osler famously said, “The good physician treats the disease; the great physician treats the patient who has the disease.” I am a strong believer in individualizing treatment plans unique to each patient based on understanding the patient as a whole and the specifics of their disease. I am committed to each patient’s care and work hard to ensure that every single patient has the most positive clinical outcome. Dr. Goldfinger is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Amit K. Verma, MD, is Chair, Department of Oncology, Associate Director of Translational Science, Montefiore Einstein Comprehensive Cancer Center, Professor, Medical Oncology and Professor, Developmental & Molecular Biology, Albert Einstein College of Medicine. Dr. Verma is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration.

Gail Roboz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Roboz is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). She is also highly rated in 45 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Roboz is currently accepting new patients.

"Dr. Joseph Jurcic is a Professor of Medicine at Columbia University Medical Center and the Director of the Hematologic Malignancies Section within the Division of Hematology/Oncology. He specializes in Medical Oncology and focuses on leukemia, myelodysplastic syndromes, and myeloproliferative disorders. Based in New York, NY, Dr. Jurcic is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. He received his M.D. from the Perelman School of Medicine at the University of Pennsylvania and completed his training at Barnes-Jewish Hospital and Memorial Sloan Kettering Cancer Center. He is board-certified in both Medical Oncology and Hematology.Dr. Jurcic's clinical expertise includes the treatment of acute and chronic leukemias, myeloproliferative neoplasms, and myelodysplastic syndromes. His research interests encompass acute myeloid leukemia, radioimmunotherapy with alpha and beta particle-emitting radioisotopes, monoclonal antibody therapy, developing novel small molecule inhibitors, and molecular monitoring of minimal residual disease. Recognized as one of New York Magazine's ""Best Doctors"" from 2014 to 2024, he has authored or co-authored over 80 articles and book chapters. He has served as the principal investigator on more than 25 clinical trials. Additionally, Dr. Jurcic lectures at national and international conferences and is the Leukemia Section Editor for The Oncologist.". Dr. Jurcic is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Jurcic is board certified in Hematology and Medical Oncology. Dr. Jurcic is currently accepting new patients.

An internationally known leader in hematology, A. Samer Al-Homsi, MD, MBA, is system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute, where he also serves as director of faculty and academic affairs in medical oncology.In his position, Dr. Al-Homsi treats patients in need of blood and marrow transplantation for blood cancers and other blood conditions. Dr. Al-Homsi attended medical school at Damascus University Faculty of Medicine, did his residency at Advocate Christ Medical Center in Illinois, and completed a fellowship at UMass Chan Medical School in Worcester, MA. He also received training and practiced in France. He came to Northwell from the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, where he was executive director of transplantation and cellular therapy. His research efforts throughout his career have focused on innovations that lead to better patient care in blood and marrow transplantation.The poet Kahlil Gibran wrote that work is love made visible, and I believe medicine is love made visible, says Dr. Al-Homsi. Every patient has unique needs, based not just on their specific condition, but also on their cultural background, family situation, and the impact of their disease. We're fortunate at Northwell to have care delivered by a large team that's there to address all those aspects.Dr. Al-Homsi is looking forward to advancing more clinical research at Northwell's Feinstein Institutes for Medical Research and at Cold Spring Harbor Laboratory. That will likely facilitate the development of more therapies that can treat patients, he says, and in a way that's safer and more effective.Dr. Al-Homsi doesn't just focus on the physical effects of conditions like leukemia, lymphoma, and multiple myeloma with decades of patient care, he also knows the tremendous value of a deeper conversation about how cancer is affecting patients mental health and everyday function. His priority is to learn about the patient first and the disease second.That perspective on patient advocacy and approaching each interaction with compassion and love is the same now as it was when he first entered medical school, he recalls. I wanted my life to matter, and to make a difference, he says. I'm not trying to change the world, but I can change patients' lives. I can change their world, and that's incredibly rewarding and meaningful. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Adult T-Cell Leukemia, Chronic T-Cell Leukemia (CTCL), and Bone Marrow Transplant. Dr. Al is board certified in American Board Of Internal Medicine/Hematology.

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Savona is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.